More Penalties With Hospital-Wide Readmission Measure

Share this content:
More Penalties With Hospital-Wide Readmission Measure
More Penalties With Hospital-Wide Readmission Measure

THURSDAY, Oct. 19, 2017 (HealthDay News) -- Transition from a condition-specific to a hospital-wide readmission measure would result in a modest increase in the number of hospitals eligible for readmission penalties and would substantially increase penalties for safety-net hospitals, according to a study published online Oct. 18 in the New England Journal of Medicine.

Rachael B. Zuckerman, Ph.D., from the Department of Health and Human Services in Washington, D.C., and colleagues used Medicare claims from 2011 through 2013 to assess the number of hospitals that were eligible for penalties. The authors examined the expected effects of changing from the condition-specific readmission measure to a hospital-wide measure on average penalties for safety-net and other hospitals (3,443 total hospitals; 688 considered safety-net hospitals). The sample included 6,807,899 and 4,392,658 admissions for the hospital-wide and condition-specific measures, respectively.

The researchers found that changing to the hospital-wide measure would make 76 more hospitals eligible to receive penalties. Penalties would be increased from 0.42±0.01 to 0.89±0.01 percent of Medicare base diagnosis-related group payments with the hospital-wide measure. It would also result in an increase in the disparity in penalties between safety-net and other hospitals, from −0.03±0.02 to 0.41±0.06 percentage points.

"A transition to a hospital-wide readmission measure would only modestly increase the number of hospitals eligible for penalties and would substantially increase the penalties for safety-net hospitals," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

California Lawsuit Claims AbbVie Paid Doctors to Prescribe Humira

California Lawsuit Claims AbbVie Paid Doctors to Prescribe ...

Claims physicians prescribed Humira because of financial kickbacks, not as best drug for patient

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-Directed IV Remifentanil Cuts Epidural Conversions

Patient-controlled remifentanil reduces proportion of conversions versus intramuscular pethidine

Pediatricians Have Role in Supporting Transgender Youth

Pediatricians Have Role in Supporting Transgender Youth

Recommendations developed for comprehensive care for youth identifying as transgender, gender diverse

is free, fast, and customized just for you!




Already a member?

Sign In Now »